Country: New Zealand
Language: English
Source: Medsafe (Medicines Safety Authority)
Lisinopril dihydrate 10.89mg equivalent to lisinopril 10 mg; ; ;
Teva Pharma (New Zealand) Limited
Lisinopril dihydrate 10.89 mg (equivalent to lisinopril 10 mg)
10 mg
Tablet
Active: Lisinopril dihydrate 10.89mg equivalent to lisinopril 10 mg Excipient: Calcium hydrogen phosphate dihydrate Ferric oxide red (CI77491) Magnesium stearate Maize starch Mannitol
Blister pack, PVC/Al, 10 tablets, 10 tablets
Prescription
Prescription
Zhejiang Huahai Pharmaceutical Co Ltd
Lisinopril is indicated in the treatment of essential hypertension and in renovascular hypertension. It may be used alone or concomitantly with other classes of antihypertensive agents.
Package - Contents - Shelf Life: Blister pack, PVDC/PVC/Al - 10 tablets - 36 months from date of manufacture stored at or below 25°C protect from light. protect from heat - Blister pack, PVDC/PVC/Al - 14 tablets - 36 months from date of manufacture stored at or below 25°C protect from light. protect from heat - Blister pack, PVDC/PVC/Al - 28 tablets - 36 months from date of manufacture stored at or below 25°C protect from light. protect from heat - Blister pack, PVDC/PVC/Al - 30 tablets - 36 months from date of manufacture stored at or below 25°C protect from light. protect from heat - Blister pack, PVDC/PVC/Al - 50 tablets - 36 months from date of manufacture stored at or below 25°C protect from light. protect from heat - Blister pack, PVDC/PVC/Al - 56 tablets - 36 months from date of manufacture stored at or below 25°C protect from light. protect from heat - Blister pack, PVDC/PVC/Al - 84 tablets - 36 months from date of manufacture stored at or below 25°C protect from light. protect from heat - Blister pack, PVDC/PVC/Al - 90 tablets - 36 months from date of manufacture stored at or below 25°C protect from light. protect from heat - Blister pack, PVDC/PVC/Al - 100 tablets - 36 months from date of manufacture stored at or below 25°C protect from light. protect from heat
2004-07-06
NEW ZEALAND DATA SHEET LISINOPRIL (TEVA) Lisinopril Tablets 5 mg, 10 mg, 20 mg Version 1.1 1 1. NAME OF THE MEDICINAL PRODUCT LISINOPRIL (Teva) 5 mg, tablet LISINOPRIL (Teva) 10 mg, tablet LISINOPRIL (Teva) 20 mg, tablet 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Lisinopril (Teva) tablets come in three strengths and contain lisinopril dihydrate equivalent to 5 mg, 10 mg or 20 mg lisinopril. 3. PHARMACEUTICAL FORM 5 MG TABLET : A light pink coloured, circular, biconvex uncoated tablet. The tablet has a break line and is embossed with ‘5’ on one side and embossed with ‘BL’ on the other side. 10 MG TABLET : A light pink coloured, circular, biconvex uncoated tablet. The tablet is embossed with ‘10’ on one side and embossed with ‘BL’ on the other side. 20 MG TABLET : A pink, circular, biconvex uncoated tablet. The tablet is embossed with ‘20’ on one side and embossed with ‘BL’ on the other side. Lisinopril dihydrate. The chemical name for lisinopril dihydrate is N-[N-[(1S)-1-carboxy-3- phenylpropyl]-L-lysyl]-L-proline dihydrate. Its structural formula is: C21H31N3O5.2H2O, Molecular weight: 441.53, CAS No.: 83915-83-7 Lisinopril dihydrate is a white to off-white crystalline powder that is soluble in water, sparingly soluble in methanol and practically insoluble in ethanol. A synthetic peptide derivative, lisinopril dihydrate is an oral long acting angiotensin converting enzyme inhibitor. It is a lysine analogue of enalaprilat (active metabolite of enalapril). 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Lisinopril is indicated in the treatment of essential hypertension and in renovascular hypertension. It may be used alone or concomitantly with other classes of antihypertensive agents. NEW ZEALAND DATA SHEET LISINOPRIL (TEVA) Lisinopril Tablets 5 mg, 10 mg, 20 mg Version 1.1 2 Lisinopril is indicated in the management of congestive heart failure as an adjunctive treatment with diuretics and, where appropriate, digitalis. Lisinopril is indicated for the treatment of haemodynamically stabl Read the complete document